Correlation Between Cullinan Oncology and Annexon

Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cullinan Oncology LLC and Annexon, you can compare the effects of market volatilities on Cullinan Oncology and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Annexon.

Diversification Opportunities for Cullinan Oncology and Annexon

0.51

Correlation Coefficient

Cullinan Oncology  Annexon

Very weak diversification

The 3 months correlation between Cullinan and Annexon is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Annexon go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Annexon

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Annexon. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 1.01 times less risky than Annexon. The stock trades about -0.13 of its potential returns per unit of risk. The Annexon is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  559.00  in Annexon on September 4, 2024 and sell it today you would lose (32.00) from holding Annexon or give up 5.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cullinan Oncology LLC  vs.  Annexon

Cullinan Oncology LLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Annexon

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Annexon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Annexon is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cullinan Oncology and Annexon

The main advantage of trading using opposite Cullinan Oncology and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.

The idea behind Cullinan Oncology LLC and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.